Camellia japonica suppresses immunoglobulin E-mediated allergic response by the inhibition of Syk kinase activation in mast cells

Clinical and Experimental Allergy

Volumn 38, Issue 5, 2008, Pages 794-804

  Lee, J H ^a   Kim, J W ^a   Ko, N Y ^a   Mun, S H ^a   Kim, D K ^a   Kim, J D ^a   Kim, H S ^b   Lee, K R ^c   Kim, Y K ^d   Radinger, M ^e   Her, E ^a   Choi, W S ^a  

^a Konkuk University   (South Korea)

^b Pusan National University   (South Korea)

^c Sungkyunkwan University   (South Korea)

^d Catholic Kwandong University   (South Korea)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Allergy; Camellia japonica; Mast cells; Src family kinase; Syk kinase

Indexed keywords

ANTIALLERGIC AGENT; CAMELLIA JAPONICA EXTRACT; PROTEIN KINASE SYK; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ANAPHYLAXIS; ANIMAL CELL; ARTICLE; CAMELLIA JAPONICA; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VIVO STUDY; MAST CELL; MEDICINAL PLANT; MOUSE; NONHUMAN; PLANT LEAF; PRIORITY JOURNAL;

ANIMALS; BASOPHILS; CAMELLIA; CELL DEGRANULATION; CELLS, CULTURED; ENZYME ACTIVATION; HUMANS; HYPERSENSITIVITY, DELAYED; HYPERSENSITIVITY, IMMEDIATE; IMMUNOBLOTTING; IMMUNOGLOBULIN E; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KOREA; MAST CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED ICR; PASSIVE CUTANEOUS ANAPHYLAXIS; PLANT EXTRACTS; PLANT LEAVES; PROTEIN-TYROSINE KINASES; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SRC-FAMILY KINASES;

EID: 42249088736     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2008.02936.x     Document Type: Article

References (41)

1. Beaven MA, Hundley TR. Mast cell related diseases: genetics, signaling pathways, and novel therapies. In : Finkel TH, Gutkind JS, eds. Signal transduction and human disease. Hoboken, NJ : John Wiley & Sons Inc., 2003 307 55.
2. Wedemeyer J, Tsai M, Galli SJ. Roles of mast cells and basophils in innate and acquired immunity. Curr Opin Immunol 2000 12 : 624 31.
3. Gilfillan AM, Tkaczyk C. Integrated signalling pathways for mast-cell activation. Nat Rev Immunol 2006 6 : 218 30.
4. Parravinci V, Gadina M, Kovarova M et al. Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat Immunol 2002 3 : 741 8.
5. Siraganian RP, Zhang J, Suzuki K, Sada K. Protein tyrosine kinase Syk in mast cell signaling. Mol Immunol 2002 38 : 1229 33.
6. Church MK, Levi-Schaffer F. The human mast cell. J Allergy Clin Immunol 1997 99 : 155 60.
7. Metcalfe DD, Kaliner M, Donlon MA. The mast cell. Crit Rev Immunol 1981 3 : 23 74.
8. Kay AB. Allergy and allergic diseases. New Engl J Med 2001a 344 : 30 7.
9. Kay AB. Allergy and allergic diseases. New Engl J Med 2001b 344 : 109 13.
10. Luskova P, Fraber P. Modulation of the FcεRI signaling by tyrosine kinase inhibitors: search for therapeutic targets of inflammatory and allergy diseases. Curr Pharmceut Des 2004 10 : 1727 37.
11. Lee JH, Ko NY, Kim NW et al. Meliae cortex extract exhibits anti-allergic activity through the inhibition of Syk kinase in mast cells. Toxicol Appl Pharmacol 2007 220 : 227 34.
12. Lee JH, Kim NW, Her E et al. Rubiae Radix suppresses the activation of mast cells through the inhibition of Syk kinase for anti-allergic activity. J Pharm Pharmacol 2006 58 : 503 12.
13. Lee JH, Chang SH, Park YS et al. In-vitro and in-vivo anti-allergic actions of Arecae semen. J Pharm Pharmacol 2004 56 : 927 33.
14. Lee JH, Seo JY, Ko NY et al. Inhibitory activity of Chrysanthemi sibirici herba extract on RBL-2H3 mast cells and compound 48/80-induced anaphylaxis. J Ethnopharmacol 2004 95 : 425 30.
15. Saitoh S, Arudchandran R, Manetz TS et al. LAT is essential for Fc(epsilon)RI-mediated mast cell activation. Immunity 2000 12 : 525 35.
16. Kirshenbaum AS, Goff JP, Semere T, Foster B, Scott LM, Metcalfe DD. Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13). Blood 1999 94 : 2333 42.
17. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophages t4. Nature 1970 227 : 680 5.
18. Kabu K, Yamasaki S, Kamimura D et al. Zinc is required for FcεRI-mediated mast cell activation. J Immunol 2006 177 : 1296 305.
19. Seldin DC, Adelman S, Austen KF et al. Homology of the rat basophilic leukemia cell and the rat mucosal mast cell. Proc Natl Acad Sci USA 1985 82 : 3871 5.
20. Theoharidies TC, Kalogeromitros D. The critical role of mast cells in allergy and inflammation. Ann NY Acad Sci 2006 1088 : 78 92.
21. Chu DH, Morita CT, Weiss A. The syk family of protein tyrosine kinases in T-cell activation and development. Immunol Rev 1998 165 : 167 80.
22. Law CL, Chandran KA, Sidorenko SP, Clark EA. Phospholipase C-gamma1 interacts with conserved phosphotyrosyl residues in the linker region of Syk and is a substrate for Syk. Mol Cell Biol 1996 16 : 1305 15.
23. Kemp SF, Lockey RF. Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol 2002 110 : 341 8.
24. Kihara H, Siraganian RP. Src homology 2 domains of Syk and Lyn bind to tyrosine-phosphorylated subunits of the high affinity IgE receptor. J Biol Chem 1994 269 : 22427 32.
25. Kimura T, Sakamoto H, Appella E, Siraganian RP. The negative signaling molecule SH2 domain-containing inositol-polyphosphate 5-phosphatase (SHIP) binds to the tyrosine-phosphorylated beta subunit of the high affinity IgE receptor. J Biol Chem 1997 272 : 13991 6.
26. Galli SJ. New concepts about the mast cells. New Eng J Med 1993 328 : 257 65.
27. Lorentz A, Klopp I, Gebhardt T, Manns MP, Bischoff SC. Role of activator protein 1, nuclear factor-kappaB, and nuclear factor of activated T cells in IgE receptor-mediated cytokine expression in mature human mast cells. J Allergy Clin Immunol 2003 111 : 1062 8.
28. Zhang C, Baumgartner RA, Yamada K, Beaven MA. Mitogen-activated protein (MAP) kinase regulates production of tumor necrosis factor-alpha and release of arachidonic acid in mast cells. Indications of communication between p38 and p42 MAP kinases. J Biol Chem 1997 272 : 13397 402.
29. Frossi B, Rivera J, Hirsch E, Pucillo C. Selective activation of Fyn/PI3K and p38 MAPK regulates IL-4 production in BMMC under nontoxic stress condition. J immunol 2007 178 : 2549 55.
30. Saitoh S, Odom S, Gomez G et al. The four distal tyrosines are required for LAT-dependent signaling in FcepsilonRI-mediated mast cell activation. J Exp Med 2003 198 : 831 43.
31. Ito S, Kodama M, Konoike M. Structure of camelliagenins. Tetrahedron Lett 1967 8 : 591 6.
32. Itokawa H, Sawada N, Murakami T. The structures of camelliagenin A, B, and C obtained from Camellia japonica L. Tetrahedron Lett 1967 8 : 597 601.
33. Itokawa H, Sawada N, Murakami T. The structures of camelliagenin A, B and C obtained from Camellia japonica L. Chem Pharm Bull 1969 17 : 474 80.
34. Yoshikawa M, Harada E, Murakami T, Matsuda H, Yamahara J, Murakami N. Camelliasaponins B1, B2, C1 and C2, new type inhibitors of ethanol absorption in rats from the seeds of Camellia japonica L. Chem Pharm Bull 1994 42 : 742 4.
35. Yoshikawa M, Murakami T, Yoshizumi S, Murakami N, Yamahara J, Matsuda H. Bioactive saponins and glycosides. V. Acylated polyhydroxyolean-12-ene triterpene oligoglycosides, camelliasaponins A1, A2, B1, B2, C1, and C2, from the seed of Camellia japonica L.: structures and inhibitory activity on alcohol absorption. Chem Pharm Bull 1996 44 : 1899 907.
36. Itokawa H, Nakajima H, Ikuta A, Iitaka Y. Two triterpenes from the flowers of Camellia japonica. Phytochemistry 1981 20 : 2539 42.
37. Nakajima H, Itokawa H, Ikuta A. Studies on the constituents of the flower of Camellia japonica (2). Yakugaku Zasshi 1984 104 : 157 61.
38. Onodera KI, Hanashiro K, Yasumoto T. Camellianoside, a novel anti-oxidant glycoside from the leaves of Camellia japonica. Biosci Biotechnol Biochem 2006 70 : 1995 8.
39. Park JC, Hur JM, Park JG et al. Inhibitory effects of Korean medicinal plants and camelliatannin H from Camellia japonica on human immunodeficiency virus type 1 protease. Phytother Res 2002 16 : 422 6.
40. Kim HM, Lee EH, Kim CY et al. Antianaphylactic properties of eugenol. Pharmacological research 1997 36 : 475 80.
41. Szabadics J, Erdelyi L. Pre-and postsynaptic effects of eugenol and related compounds on Helix pomatia L. Acta Biol Hung 2000 51 : 265 73.